SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-013661
Filing Date
2018-05-15
Accepted
2018-05-15 17:09:28
Documents
43
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q gnpx-10q_20180331.htm 10-Q 890721
2 EX-31.1 gnpx-ex311_10.htm EX-31.1 16426
3 EX-31.2 gnpx-ex312_9.htm EX-31.2 17937
4 EX-32.1 gnpx-ex321_8.htm EX-32.1 8665
  Complete submission text file 0001564590-18-013661.txt   2798959

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT gnpx-20180331.xml EX-101.INS 332292
6 XBRL TAXONOMY EXTENSION SCHEMA gnpx-20180331.xsd EX-101.SCH 31953
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gnpx-20180331_cal.xml EX-101.CAL 21744
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gnpx-20180331_def.xml EX-101.DEF 87503
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE gnpx-20180331_lab.xml EX-101.LAB 243721
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gnpx-20180331_pre.xml EX-101.PRE 175326
Mailing Address 100 CONGRESS AVENUE SUITE 2000 AUSTIN TX 78701
Business Address 100 CONGRESS AVENUE SUITE 2000 AUSTIN TX 78701 512-708-0155
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

IRS No.: 900772347 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38244 | Film No.: 18837665
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1